News
Covid, Moderna and FDA
Digest more
2h
WOODTV.com on MSNModerna gets full FDA approval for kids COVID-19 vaccineThe company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...
Moderna stock surged on Tuesday amid what has been a lively past few days for the pharmaceutical industry. The tumultuous ...
4d
Barchart on MSNThe Next Moderna? This Clinical-Stage Biotech Has Breakout Potential.Moderna (MRNA), an undervalued name in the biotech space, rose to prominence during the COVID-19 pandemic. This occurred when ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results